Eye on Professional Skin Care: Will SkinMedica Remain Unchanged After the Pfizer-Allergan Merger?
Over the last two weeks, a lot has been written—and not all of it complimentary—about the Pfizer and Allergan merger that will create on completion the world’s largest pharmaceutical company valued at $160 billion. Industry analysts and financial, legal, and political heavyweights are unanimous in their criticism of the ethics of the merger, announced on